Welcome to the InfoSci Platform
Intellectual Capital and Business Performance of Pharmaceutical Firms in Kenya

Intellectual Capital and Business Performance of Pharmaceutical Firms in Kenya

James Mark Ngari
Copyright: © 2017 |Pages: 22
ISBN13: 9781522510314|ISBN10: 1522510311|EISBN13: 9781522510321
DOI: 10.4018/978-1-5225-1031-4.ch011
Cite Chapter Cite Chapter

MLA

Ngari, James Mark. "Intellectual Capital and Business Performance of Pharmaceutical Firms in Kenya." Corporate Espionage, Geopolitics, and Diplomacy Issues in International Business, edited by Bryan Christiansen and Fatmanur Kasarcı, IGI Global, 2017, pp. 188-209. https://doi.org/10.4018/978-1-5225-1031-4.ch011

APA

Ngari, J. M. (2017). Intellectual Capital and Business Performance of Pharmaceutical Firms in Kenya. In B. Christiansen & F. Kasarcı (Eds.), Corporate Espionage, Geopolitics, and Diplomacy Issues in International Business (pp. 188-209). IGI Global. https://doi.org/10.4018/978-1-5225-1031-4.ch011

Chicago

Ngari, James Mark. "Intellectual Capital and Business Performance of Pharmaceutical Firms in Kenya." In Corporate Espionage, Geopolitics, and Diplomacy Issues in International Business, edited by Bryan Christiansen and Fatmanur Kasarcı, 188-209. Hershey, PA: IGI Global, 2017. https://doi.org/10.4018/978-1-5225-1031-4.ch011

Export Reference

Mendeley
Favorite

Abstract

Intellectual capital is an investment in the organization and it is perceived to be a strategic resource and a source of competitive advantage. The purpose of this chapter is to test the relationship between intellectual capital and business performance of pharmaceutical firms in Kenya. The specific objectives are to determine whether human capital, structural capital and relational capital influence business performance of pharmaceutical firms in Kenya. The results indicate that human capital, structural capital and relational capital influence business performance of pharmaceutical firms in Kenya. Human capital and structural capital relationship strongly exist among the studied pharmaceutical firms and significantly influenced business performance positively. In addition, the study confirmed that human capital, structural capital and relational capital are dimensions of intellectual capital. The developed model confirm that the theory fitted data with fit indices above or below the required thresholds and the empirical results provided strong support for the model.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.